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Introduction
The cell cycle is orchestrated by the coordinated actions of sev-
eral kinases whose activity is regulated positively by cyclins 
(Murray, 2004) and negatively by cyclin-dependent kinase (cdk) 
inhibitors (CKIs; Harper, 1997). Entry into the cell cycle from 
previous quiescence depends on the activation of G1-phase 
 kinases.  These  chiefl  y include cdk4 and cdk6 kinases (cdk4/6) 
  activated by D-type cyclins during early to mid-G1 phase and 
the cdk2 kinase, whose activation at the G1/S boundary depends 
on cyclins E and A (Sherr, 1994; Sherr and Roberts, 2004). 
The single most important substrate of these cdks is the retino-
blastoma protein (pRb), whose phosphorylation is a prerequi-
site for S-  phase initiation (Weinberg, 1995). Recent results have 
shown that cell cycle reentry is facilitated by the activity of the 
cyclin C–cdk3 complex, which is also a pRb kinase (Ren and 
Rollins, 2004).
CKIs belong to two families known as INK4 and Cip/Kip. 
The INK4 family comprises four members that are indicated 
according to their approximate molecular size as p15, p16, p18, 
and p19. These inhibitors specifi  cally bind cdk4/6, preventing 
  heteroduplex formation with D cyclins. Cip/Kip inhibitors 
  include p21, p27, and p57. These molecules show much wider 
binding specificity, as they are able to bind essentially all 
  cyclin–cdk complexes and, albeit with lower affi  nity, free cyclins 
(Harper, 1997). In addition to their inhibitory role on cell cycle 
kinases, Cip/Kip family molecules facilitate cyclin–cdk complex 
formation (LaBaer et al., 1997); the precise balance between 
these two opposite activities is still debated.
The vast majority of the cells that make up a vertebrate’s 
body spend most of their time in different nonproliferating states, 
which are collectively labeled as G0 phase of the cell cycle. 
Physiologically nonproliferating cells can be found in at least 
three distinguishable conditions, including reversible quies-
cence, replicative senescence, and the postmitotic state that char-
acterizes and defi  nes terminal differentiation. These three states 
are quite disparate with respect to both their phenomenology and 
the molecular mechanisms responsible for proliferative arrest.
Quiescence is defi  ned as a temporary, reversible absence 
of proliferation. This state can be induced by a variety of condi-
tions including, among others, growth factor deprivation, con-
tact inhibition, and loss of anchorage (Coller et al., 2006). 
Quiescence can be usually readily reverted by removing the 
conditions that determined it. Indeed, the succession of events 
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n adult vertebrates, most cells are not in the cell cycle 
at any one time. Physiological nonproliferation states 
encompass reversible quiescence and permanent 
  postmitotic conditions such as terminal differentiation and 
replicative senescence. Although these states appear to be 
attained and maintained quite differently, they might share 
a core proliferation-restricting mechanism. Unexpectedly, 
we found that all sorts of nonproliferating cells can be 
mitotically reactivated by the sole suppression of histotype-
speciﬁ  c cyclin-dependent kinase (cdk) inhibitors (CKIs) in 
the absence of exogenous mitogens. RNA interference–
mediated suppression of appropriate CKIs efﬁ   ciently 
  triggered DNA synthesis and mitosis in established and 
primary terminally differentiated skeletal muscle cells 
(myotubes), quiescent human ﬁ  broblasts, and senescent 
human embryo kidney cells. In serum-starved ﬁ  broblasts 
and myotubes alike, cell cycle reactivation was critically 
mediated by the derepression of cyclin D–cdk4/6 complexes. 
Thus, both temporary and permanent growth arrest must 
be actively maintained by the constant expression of CKIs, 
whereas the cell cycle–driving cyclins are always present 
or can be readily elicited. In principle, our ﬁ  ndings could 
ﬁ  nd wide application in biotechnology and tissue repair 
whenever cell proliferation is limiting.
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that follow exit from quiescence has long served as the principal 
experimental paradigm for cell cycle studies. Quiescence is 
usually associated with very low levels of cyclins, and it is gen-
erally believed that such low levels are its main determinants 
(Ekholm and Reed, 2000; Sherr and Roberts, 2004). By way of 
example, serum-starved quiescent fi  broblasts express very low 
amounts of cyclins associated with any phase of the cell cycle. 
Serum refeeding triggers exit from quiescence by bringing about 
a surge of cyclin D expression followed by cyclins E, A, and B 
in a coordinated succession (Kerkhoff and Rapp, 1997). Unlike 
cyclins, G1-controlling cdks are not primarily regulated at the 
protein expression level, thus making their cognate cyclins the 
limiting factors for cell cycle reentry (Ekholm and Reed, 2000).
Replicative senescence, which is also called cell aging, is 
normally a permanent state of proliferation arrest. It was origi-
nally described as an intrinsic limit to the number of duplica-
tions that cells can undergo in vitro (Hayfl  ick and Moorhead, 
1961). More recently, replicative senescence has come to be 
viewed as the result of telomere shortening, damage at the mo-
lecular level, or both (Herbig and Sedivy, 2006). Indeed, pre-
venting telomere attrition (Bodnar et al., 1998) and/or DNA 
damage accumulation (Parrinello et al., 2003) often results in 
cell immortalization. Unlike their reversibly quiescent counter-
parts, aging cells can express high levels of G1 cyclins, which 
are nonetheless devoid of associated kinase activity (Dulic 
et al., 1993). Removal of p53 (Bischoff et al., 1990) or pocket 
(pRb family) proteins (Shay et al., 1991; Sage et al., 2000) has 
been shown to weaken replicative senescence or prevent it 
  altogether. In most cases, both pathways must be disrupted to 
produce full immortalization (Shay et al., 1991). The involvement 
of CKIs in establishing cell aging has long been recognized. 
p21 and/or p16 expression has been shown to associate with 
  senescence in a variety of cell types (Herbig and Sedivy, 2006), 
whereas the role of p27 is somewhat more restricted (Bringold 
and Serrano, 2000). Ablation of relevant CKIs such as p21 
(Brown et al., 1997) or p16 (Itahana et al., 2003) before senes-
cence takes place can delay or prevent its establishment or 
reduce resistance to immortalization. p21 is a transcriptional 
target and is one of the most important effectors of the DNA 
damage response mediated by p53. p16 prevents the formation 
of cyclin D–cdk4/6 kinase complexes, thus interfering with pRb 
phosphorylation (Harper, 1997). In addition, it has been shown 
that injection of anti-p53 antibodies into senescent fi  broblasts 
induces cell cycle reentry along with a reduction of p21 expres-
sion (Gire and Wynford-Thomas, 1998). Thus, CKIs belong to 
regulatory pathways that are essential for the onset of senescent 
arrest; surprisingly, however, whether or not they are absolutely 
required for the maintenance of senescence as opposed to its 
  establishment is not known (Beausejour et al., 2003).
Terminal differentiation defi   nes cells that permanently 
exit the cell cycle in the course of acquiring functional special-
ization. In extreme cases, terminally differentiated (TD) cells such 
as keratinocytes and erythrocytes lose their nuclei altogether, 
thus irreversibly relinquishing their ability to divide. However, 
most TD cells keep a full replicative apparatus while nonethe-
less becoming extremely refractory to spon  taneous or induced 
cell cycle reactivation (Tiainen et al., 1996a). The molecular 
basis of such refractoriness is incompletely understood. It 
has been shown that pRb is absolutely necessary for the 
  establishment of terminal differentiation in several histotypes, 
including skeletal muscle myotubes (Schneider et al., 1994). 
However, pRb is not required for maintenance of the post-
mitotic state (Camarda et al., 2004; Huh et al., 2004). Although 
several cyclins are down-regulated early upon skeletal muscle 
differentiation (Ohkubo et al., 1994; Tiainen et al., 1996b), the 
up-regulation of several CKIs has been shown to correlate with 
myotube formation. p18 (Myers et al., 2004), p21 (Halevy et al., 
1995; Parker et al., 1995), p27 (Zabludoff et al., 1998; Messina 
et al., 2005), and p57 (CDKN2C, CDKN1A, 1B, and 1C, 
 respectively; Zhang et al., 1999) have all been indicated to partici-
pate in control of the cell cycle in muscle differentiation, making 
it diffi  cult to sort their respective functions. Most conclusions 
concerning the role played by CKIs in muscle differentiation 
rely on knockout animals (Myers et al., 2004), whose defi  -
ciencies may have been compensated for in the course of onto-
genesis. Although useful to investigate the signifi  cance of CKIs 
in establishing the postmitotic state, such animals are ill suited 
to assess their relevance in the maintenance of terminal differ-
entiation. Mice lacking one or more CKIs before the onset of 
terminal   differentiation cannot help distinguish between 
continuing   proliferation during differentiation and cell cycle 
reentry after the establishment of the postmitotic state.
The three aforementioned proliferation arrest states be-
have differently at the molecular level. For instance, the forced 
expression of cyclin E–associated kinase activity can induce 
cell cycle reentry in quiescent cells (Lukas et al., 1997; Connell-
Crowley et al., 1998) but not TD myotubes (Latella et al., 2001). 
Similarly, the functional suppression of p53 can reactivate se-
nescent fi  broblasts (Gire and Wynford-Thomas, 1998) but not 
TD cells (Crescenzi et al., 1995). The postmitotic state cannot 
be established in myotubes in the absence of pRb (Schneider 
et al., 1994), whereas this protein is not essential for initiat-
ing either quiescence or cell senescence (Sage et al., 2000). 
Conversely, the removal of pRb reactivates the cell cycle in qui-
escent and senescent cells (Sage et al., 2003) but not in TD 
myotubes (Camarda et al., 2004; Huh et al., 2004).
Despite their conspicuous differences, conditions sharing 
nonproliferation as an endpoint might also share a core mecha-
nism responsible for their common phenotype. In this study, we 
suppress the expression of various CKIs in cells representative 
of all three states. Unexpectedly, CKI removal led to widespread 
cell cycle reentry in all cases even in the absence of exoge-
nous growth factors. Thus, all states of nonproliferation depend 
  critically on the constant expression of cell cycle inhibitors. 
We conclude that even the deepest, genuinely permanent growth 
arrest states are the result of a decision that must be continu-
ously reasserted by the cell.
Results
CKI suppression reactivates the cell cycle 
in TD myotubes
We have previously shown that the cell cycle can be reactivated 
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by restoring physiological levels of cdk4/6 activity. However, 
such restoration requires gross overexpression of both cyclin 
D1 and cdk4, suggesting the need to overwhelm preponderant 
levels of CKIs (Latella et al., 2001). We sought to alleviate the 
requirement for cyclin D1–cdk4 overexpression by identifying 
and removing functionally signifi  cant CKIs in myotubes, which 
is a prototypic TD model system.
To determine which CKIs are most relevant in our experi-
mental settings, mouse C2C12 myoblasts were induced to ter-
minally differentiate into myotubes that were then coinfected 
with recombinant adenoviruses carrying cyclin D1 and cdk4. 
Infection multiplicities were chosen so as to achieve a moderate 
overexpression of both moieties in order to maximize capture of 
available inhibitory molecules without causing cell cycle reentry. 
Immunoprecipitations were performed with antibodies to 
cdk4 that were equally capable of precipitating free cdk4 and its 
cyclin D complexes. The coprecipitated molecules were electro-
phoretically resolved (Fig. 1 A). Several specifi  cally precipitated 
molecules were identifi  ed by liquid chromatography/tandem 
mass spectrometry. Most relevant among these were mouse 
  cyclin D3 and, as the only representative of CKIs, p21 (Fig. 1 A).
In an effort to reduce the load of CKIs in myotubes to fa-
cilitate cell cycle reactivation, we suppressed p21 expression by 
RNAi (Fig. 1 B). Unexpectedly, the sole suppression of p21 
brought about a massive reentry of myotubes into the cell cycle, 
as shown by immunofl   uorescent detection of incorporated 
BrdU (Fig. 1 C). DNA synthesis took place equally well in the 
presence of 5% FBS and in the absence of exogenous growth 
factors. Frequent mitotic fi  gures were noted in the reactivated 
myotubes, although mitoses were nearly always morphologi-
cally aberrant. Such mitoses were quickly followed by apop-
totic death as detected by TUNEL staining 48 h after RNAi: 
40% of the p21-depleted myotubes were TUNEL positive ver-
sus 14.3% of the control cells. Both abnormal mitoses and cell 
death resemble those described in the case of viral oncogene–
reactivated muscle cells (Latella et al., 2000). The specifi  city of 
p21 RNAi was ascertained by comparing the ability of four 
  different double-stranded RNA oligonucleotides (siRNAs) for 
p21 to lower p21 protein levels and induce DNA synthesis in 
C2C12 myotubes (Fig. S1 A, available at http://www.jcb.org/
cgi/content/full/jcb.200608109/DC1).
The role played by the other known CKIs was systemati-
cally investigated by interfering with each of them singularly or 
in selected combinations (Fig. 1 D). The effectiveness of RNAi 
in reducing the expression of the different CKIs is shown in 
Fig. S1 (B–D). Ablation of no other single CKI stimulated BrdU 
incorporation in myotubes. Interference with p27 by itself also 
did not trigger DNA synthesis but reproducibly induced a small 
increase in the percentage of myotubes that were reactivated by 
interfering with p21 (Fig. 1 D). Fig. S2 (A–C; available at http://
www.jcb.org/cgi/content/full/jcb.200608109/DC1) shows the 
association of three CKIs with cyclin D1, cyclin D3, or cdk4 in 
both myoblasts and myotubes. Total and cdk4-bound p21 and 
p27 were absolutely quantitated (Fig. S2 D). The relevance of 
Figure 1.  Identiﬁ  cation of relevant CKIs in myotubes and effects of their suppression. (A) Electrophoretic gel separation of proteins immunoprecipitated 
with an anti-cdk4 (α-cdk4) antibody or control Igs (IgG) from C2C12 myotubes. A silver-stained gel is shown here. Mass spectrometry was performed on 
bands excised from a Coomassie-stained gel loaded with 50 times as much total protein. Bands that appeared to be uniquely present in the cdk4 lane were 
processed for mass spectrometry identiﬁ  cation. Corresponding portions of the control lane were processed identically. Bands containing p21 and cyclin 
D3 are indicated. (B) Western blot analysis of p21 in whole-cell lysates from C2C12 myotubes 48 h after transfection with a pool of four p21 siRNAs or 
control siRNA. (C) Immunoﬂ  uorescence staining of C2C12 myotubes for BrdU (green) and MyHC (red). (D and E) Percentages of BrdU-positive C2C12 (D) 
and MSC (E) myotubes 48 h after interference for single or multiple CKIs as indicated. Data are presented as means and SDs (error bars) of up to ﬁ  ve 
  experiments. (F) Primary human myotubes were triple transfected with siRNAs for p21, p27, and p18 and were double immunostained for BrdU (green) 
and MyHC (red) 48 h later. Ctr, control; β-tub, β-tubulin, which was used as a loading control. Bars, 50 μm.JCB • VOLUME 176 • NUMBER 6 • 2007  810
p21 does not descend from its abundance, at least in comparison 
with p27. Thus, the pivotal role of p21 in maintenance of the 
postmitotic state in C2C12 myotubes is dictated by variables 
other than mere cellular concentration.
CKI-RNAi experiments similar to those performed with 
C2C12 cells were performed with primary myoblasts (mouse 
satellite cells [MSCs]) freshly explanted from FVB mice. Fig. 1 E 
shows that in myotubes derived from these cells, multiple 
CKIs are involved in maintenance of the postmitotic state. 
  Although in primary myotubes, ablation of p21 alone elicits very 
little BrdU incorporation, successive suppression of additional 
CKIs progressively increases the percentage of reactivated cells. 
However, interference with single CKIs other than p21 elicited 
no reactivation (negative data not depicted); even the combined 
suppression of p18, p27, and p57 was completely ineffective 
unless p21 was also suppressed (Fig. 1 E, right two histograms). 
These results suggest that key cdk complexes in MSC myotubes 
are controlled primarily by p21, whereas other CKIs take charge 
of suppressing cdk activity upon the loss of p21. Similarly, pri-
mary human myotubes incorporated BrdU (Fig. 1 F) and went 
through aberrant mitoses (not depicted) after the simultaneous 
ablation of p21, p18, and p27. Altogether, the results described 
thus far show that postmitotic myotubes can be reactivated by 
the sole removal of critical CKIs even in the absence of exoge-
nous mitogenic stimuli. In turn, this suggests that fully compe-
tent cyclin–cdk complexes are present, although normally 
inhibited, even in permanently proliferation-arrested cells.
The activity of cyclin D3–containing 
complexes is responsible for cell cycle 
reactivation in myotubes
Reactivation of the cell cycle in the absence of exogenous 
growth factors presented an apparent paradox. Growth factors 
are required for cyclin D1 synthesis and assembly of cyclin D–
cdk4/6 complexes (Sherr, 1995), which should be necessary to 
ignite a new cell cycle. Because the immunoprecipitation experi-
ments have shown that sizable amounts of endogenous cyclin D3 
associate with cdk4 (Figs. 1 A and S2 E), we hypothesized that 
preformed complexes containing at least cyclin D3, cdk4, and 
p21 are present in TD muscle cells. Indeed, similar complexes 
have been described in C2C7 myotubes (Cenciarelli et al., 
1999). Such preexisting complexes would require neither de novo 
synthesis nor assembly, thus being growth factor independent. 
The subtraction of p21 would allow cell cycle–promoting 
kinase activity to be expressed. This model fi  nds strong support 
in a published quantitative appraisal of cell cycle–regulatory 
molecules in C2C12 myotubes showing low combined levels of 
D-type cyclins with a 3:1 prevalence of cyclin D3 over cyclin 
D1 (Wang and Walsh, 1996). Western blot analyses shown in 
Fig. S2 E agree qualitatively with this previous study.
Our model made verifi   able predictions: impairment of 
  either cyclin D3 or cdk4/6 should abrogate the effects of p21 
  removal. Indeed, in C2C12 myotubes, suppression of cyclin D3 
or infection with a recombinant adenovirus carrying a dominant-
negative mutant of Cdk4 (dnK4) abolished BrdU incorpo-
ration stimulated by interference with p21 (Table I). To assess 
the specifi  city of these results, similar experiments were per-
formed with double p21/cyclin D1 RNAi. Interference with 
  cyclin D1 determined only a modest reduction in myotube DNA 
synthesis in comparison with p21 RNAi alone (unpublished 
data). The specifi  city of dnK4 activity was verifi  ed by express-
ing it 24 h after p21 RNAi. In this case, there was no reduc-
tion in BrdU incorporation, as the newly activated cell cycle 
had already progressed past the point where cdk4/6 activity is 
required (Table I).
As also entailed by our model, interference with p21 
should bring about substantial cdk4 kinase activity, which 
should be abrogated by the functional ablation of either cdk4 or 
cyclin D3. To test this prediction, C2C12 myotubes were sub-
jected to RNAi for p21 either alone or in combination with 
  cyclin D3 RNAi or infection with dnK4. Fig. 2 A shows that p21 
protein levels were reduced in all p21-interfered cultures com-
pared with myotubes transfected with control siRNA. Cyclin D3 
protein levels were also profoundly decreased by the corre-
sponding siRNA. In agreement with the model, cdk4 activity, 
which is absent in control-transfected TD muscle cells, was 
readily measured in p21-interfered myotubes at levels at least 
comparable with those found in proliferating myoblasts (Fig. 2 A). 
Such activity became undetectable upon either dnK4 infection 
or cyclin D3 RNAi. The specifi  city of cyclin D3 interference 
was verifi  ed by Western blot and cell cycle reentry analyses 
(Fig. S3, available at http://www. jcb.org/cgi/content/full/jcb 
.200608109/DC1), as already performed for p21. We noticed 
that p21 protein levels, which were already much reduced by 
p21 RNAi alone, were further lowered by simultaneous trans-
fection of siRNA for cyclin D3 (Fig. 2 A and see Fig. 4 A). 
 Because p21 is known to facilitate cyclin–cdk complex assembly 
(LaBaer et al., 1997), it was conceivable that exceedingly low 
levels of p21 rather than cyclin D3 suppression might be re-
sponsible for impairing cell cycle reactivation. To exclude this 
Table I. Abrogation of BrdU incorporation in C2C12 myotubes by cyclin D3 suppression or dnK4 expression
Experiment PT PT only PT + cyclin D3 siRNA PT + dnK4
Percent BrdU
+ at 24 h Control RNA 0 0 0
p21 siRNA 30 <1 <1
Percent BrdU
+ at 48 h Control RNA 0 0 0
p21 siRNA 68 <1 <1
dnK4 added 24 h after RNAi Control RNA 0 ND 0
p21 siRNA 50 ND 50
PT, primary transfection. Values are percentages of BrdU-positive myotubes.CKIS IN MAINTENANCE OF PROLIFERATION ARREST • PAJALUNGA ET AL. 811
possibility, we interfered with cyclin D3 and cotransfected pro-
gressively decreasing amounts of p21 siRNA in C2C12 myo-
tubes (Fig. 2 B). Double transfection with cyclin D3 and 1.7 nM 
p21 RNA oligonucleotides yielded p21 levels comparable with 
those obtained with p21 siRNA alone, yet BrdU incorporation 
was still entirely suppressed. Thus, the suppression effect can 
be ascribed entirely to cyclin D3 interference rather than to its 
modest indirect effect on p21 protein levels.
To explore the reasons why cyclin D3 plays a decisive role 
in the reactivation of C2C12 myotubes upon p21 removal, we 
measured cyclin D1– and cyclin D3–associated kinase activities 
in C2C12 myoblasts and in myotubes transfected with p21 or 
control siRNA. Fig. 3 shows that in myoblasts, the kinase activity 
associated with cyclin D3 is three times as high as that of cyclin 
D1. In control myotubes, there is virtually no measurable cyclin D–
linked kinase activity. p21 RNAi in myotubes brought about a 
marked decrease in cyclin D1 levels and a much more modest 
reduction of cyclin D3, which is consistent with the stabilizing 
role of p21 (Bagui et al., 2003). Although in p21-interfered 
myotubes the activities associated with both cyclin D1 and D3 
raise, the latter is eightfold higher than that of cyclin D1. Thus, 
the vast majority of cyclin D–associated kinase activity in p21-
depleted myotubes is carried by cyclin D3, which is the most 
abundant D-type cyclin in these cells (Wang and Walsh, 1996), 
explaining its pivotal role in myotube reactivation.
Altogether, these results lead us to conclude that in myo-
tubes, preassembled, potentially competent cyclin D3–cdk4/6 
complexes are held inactive chiefl  y by p21. CKI removal acti-
vates the kinase, allowing myotubes to reenter the cell cycle. 
To our knowledge, this is the fi  rst instance of reactivation of 
TD cells by subtraction of an endogenous inhibitor as opposed 
to the forced expression of exogenous activators.
Cdk4/6 is the direct target of CKI 
removal in myotubes
Cip/Kip family CKIs have the ability to bind most cyclins and 
cdks (Sherr and Roberts, 1999). As a consequence, removal of 
Figure 2.  cdk4-associated kinase activity in CKI-interfered C2C12 
  myotubes. (A) C2C12 myotubes were infected with an adenovirus carrying 
dnK4 or a control virus (Ad-ctr) and/or were transfected 6 h later with 
  siRNAs for the indicated molecules. (top) Western blot (WB) analyses of the 
indicated proteins in whole-cell lysates prepared 24 h after transfection. 
Proliferating myoblasts are shown for reference. (bottom) cdk4-associated 
kinase activity measured using GST-Rb as the substrate in immunoprecipi-
tates obtained with an anti-cdk4 antibody from the same lysates as in the 
top panel. cdk4 was quantitated by Western blotting in the immunoprecipi-
tates as a control for precipitation efﬁ  ciency. (B) C2C12 myotubes (Mt) 
were transfected with p21 siRNA #4 (Fig. S1 A, available at http://www
.jcb.org/cgi/content/full/jcb.200608109/DC1) at the indicated concen-
trations in the presence or absence of 5 nM siRNA to cyclin D3. An identical 
culture was transfected with control siRNA. (top) Western blot analysis of 
p21 in whole-cell lysates collected 48 h after transfection. l ctr, loading 
control. (bottom) Percentages of BrdU-positive myotubes.
Figure 3.  Cyclin D1– and cyclin D3–associated kinase activities in p21-
  interfered myotubes. C2C12 myotubes were transfected with control or p21 
siRNA, and immunoprecipitations for both cyclins were performed side 
by side 22 h later. Proliferating myoblasts synchronized in mid-G1 phase 
(see Materials and methods) are shown for reference. (A, top) Cyclin D1–
associated kinase activity was measured using recombinant GST-Rb as the 
substrate. Western blot analysis of cyclin D1 in whole-cell lysates and 
  immunoprecipitations are shown. (bottom) Cyclin D3–associated kinase 
activity measured as in the top panel. IgG, immunoprecipitation of myo-
tube lysates with normal Igs. β-tubulin loading controls for whole-cell lysates 
are shown in Fig. S2 (A and B, available at http://www.jcb.org/cgi/ 
content/full/jcb.200608109/DC1). (B) Densitometry-assisted quantitation 
of cyclin D1– and cyclin D3–associated kinase activities shown in A. See 
Materials and methods for details. Ctr, control.JCB • VOLUME 176 • NUMBER 6 • 2007  812
p21 or other Kip-type CKIs might derepress G1 kinases other 
than cdk4/6, most importantly the kinases associated with 
cyclin E. To investigate this possibility, C2C12 myotubes were 
transfected with control siRNA or various combinations of 
  siRNAs for p21, p27, and cyclin D3. Fig. 4 A shows that the corre-
sponding protein levels were effectively reduced. Substantial 
activity was found in cyclin E immunoprecipitates from myo-
tubes interfered for p21 or p21 and p27. However, such 
activity was essentially abrogated by cyclin D3 RNAi (Fig. 4 B), 
indicating that the cyclin E–associated kinase is triggered as a 
result of the previous activation of cyclin D3–containing com-
plexes. This result is in keeping with the notion that ordinarily, 
the activation of cdk2 is preceded by and is partially dependent 
on previous cdk4/6 fi  ring (Sherr and Roberts, 2004). In the pres-
ent case, the removal of CKIs might be supposed to free cyclin 
E–cdk2 complexes, but cyclin E–associated kinase activity still 
depends on previous cdk4/6 activation. Fig. 4 C shows that upon 
cyclin D3 RNAi, the association of residual p27 with cyclin E 
is enhanced in spite of the strong reduction in p27 total levels, 
possibly as a result of diminished competition from c  yclin 
D3–containing complexes. This fi  nding provides a plausible 
me  chanistic explanation for the lack of cdk2 activation upon 
  simultaneous removal of CKIs and cyclin D3. Altogether, these 
results indicate that in myotubes, the primary target of CKI-
  mediated inhibition is not a cyclin E–driven kinase but rather a 
cyclin D3–cdk4/6 complex. This conclusion is also in agree-
ment with our previous results showing that TD myotubes can 
be reactivated by physiological levels of cdk4 activity but not by 
the cdk2 kinase even if hyperactive (Latella et al., 2001).
CKIs can substitute for one another 
in preserving the postmitotic state
We wished to investigate whether different CKIs could substi-
tute for one another upon the selective suppression of one of 
them. We selected a well-studied model system: mouse embryo 
fi  broblasts (MEFs) converted into muscle cells by the expres-
sion of MyoD (Figliola and Maione, 2004; Vaccarello et al., 
2006). Wild-type and p21
−/− MEFs were infected with a MyoD-
carrying adenovirus and were induced to differentiate into myo-
tubes (myotubes from MyoD-converted MEFs [MEF-Mts]). TD 
myotubes thus obtained were subjected to RNAi for multiple 
CKIs. Similar to C2C12- and MSC-derived myotubes, wild-
type MEF-Mts were reactivated only if the suppressed CKIs 
  included p21. In particular, the suppression of p27 or p57 
singularly or in various combinations could not elicit DNA syn-
thesis (negative data not depicted). On the contrary, a meaningful 
fraction of p21
−/− MEF-Mts were reactivated by the subtraction 
of either p27 or p57 (Fig. 5). Combinations involving more 
than one CKI allowed even higher percentages of myotubes 
to reenter the cell cycle. Thus, as suggested by multiple RNAi 
experiments (Fig. 1, D and E), diverse CKIs can functionally 
replace p21 in maintenance of the postmitotic state.
Quiescent human ﬁ  broblasts 
are reactivated by CKI removal
Prompted by the results obtained with TD myotubes, we asked 
whether other physiological nonproliferative states also need 
constant maintenance by CKIs. RNAi experiments were per-
formed with low passage primary mouse (not depicted) and 
 human  fi  broblasts (Fig. 6, A and B) that were made quiescent by 
48-h serum starvation. Interference with p21 alone or in associ-
ation with p27 and/or p18 in the presence of 0.1% FBS was up 
to 82% as effi  cient in inducing cell cycle reentry as refeeding 
with 10% serum (Fig. 6 B). Mitotic fi  gures were much more 
frequent among the CKI-interfered cells than in those trans-
fected with control siRNA (unpublished data). To assess whether 
Figure 4.  Kinase activity and CKIs associated with cyclin E in CKI-
  interfered C2C12 myotubes. (A) Western blot analysis of speciﬁ  c proteins 
in C2C12 myotubes subjected to single or multiple RNAi. Cells were trans-
fected with siRNAs for the indicated molecules, and whole-cell lysates were 
prepared 30 h later. These lysates are the same as those used to immuno-
precipitate cyclin E and measure cyclin E–associated kinase activity in B. 
Proliferating myoblasts are shown for reference. β-tubulin (β-tub) is shown 
as a loading control in each of two separate blots. (B) C2C12 myotubes 
were transfected with siRNAs for the indicated molecules. Cyclin E–
associated kinase activity on histone H1 was measured 30 h after transfection 
in anti–cyclin E immunoprecipitates. Immunoprecipitates were analyzed for 
p21 and cdk2. (C) C2C12 myotubes were treated as in A, and Western 
blot analyses of the whole-cell lysates and immunoprecipitates were 
  performed. β-tubulin is shown as a loading control; cdk2 veriﬁ  es immuno-
precipitation efﬁ  ciency. IgG, immunoprecipitation performed on myotube 
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the reactivated cells are capable of substantial proliferation, 
 serum-starved  p21-interfered  fi  broblasts were kept in culture 
medium containing 0.1% FBS and were counted in the 4 d after 
RNAi. Fig. 6 C shows that p21-depleted fi  broblasts doubled in 
four days despite the absence of added growth factors, whereas 
control cells proliferated negligibly. Cell division was not 
accompanied by an appreciable increase in cell death: the 
percentage of TUNEL-positive p21-interfered cells never ex-
ceeded that of control fi  broblasts (unpublished data).
Importantly, cell cycle reentry driven by CKI RNAi was 
again completely abrogated by either cyclin D3 RNAi or dnK4 
expression (Fig. 6 B). As a specifi  city control, although dnK4 
also abolished serum-mediated cell cycle reentry, cyclin D3 
RNAi reduced serum-promoted reactivation only partially, 
which is consistent with the notion that in human fi  broblasts, 
serum acts mainly via cyclin D1 (Baldin et al., 1993). Immuno-
precipitation and Western blot analyses show that low levels of 
all three D cyclins are present in quiescent fi  broblasts along 
with levels of cdk4 and cdk6 as high as those found in prolifer-
ating cells (Fig. S4, A and B; available at http://www.jcb.org/
cgi/content/full/jcb.200608109/DC1). However, only cyclins D1 
and D3 are found associated with cdk4 (Fig. S4 C). Although 
the suppression of cyclin D3 abolishes the p21 RNAi–mediated 
reactivation of these cells (Fig. 6 B), we cannot exclude a pro-
liferative role for cyclin D1–containing complexes.
A quantitative evaluation of p21, p27, and p16 (Fig. S4, 
D–F) suggests that, as in the case of myotubes, the absolute ex-
pression level of a cell cycle inhibitor is not the primary deter-
minant of its relevance in the maintenance of growth arrest. 
These results agree with and expand upon a previous study 
showing that the reduction of p21 levels induces mitotic reacti-
vation of serum-starved fi  broblasts (Nakanishi et al., 1995). Our 
data indicate that in fi  broblasts as well as myotubes, cyclin D3–
cdk4/6 complexes are present and potentially functional even 
during quiescence. Furthermore, they show that multiple CKIs 
are involved in silencing their activity.
CKI suppression triggers proliferation 
of senescent human cells
Finally, we investigated the role of CKIs in the maintenance of 
proliferative senescence. Primary human embryo kidney (HEK) 
cells have a limited proliferative life span in vitro (Counter 
et al., 1992). Young cells are small and elongated, but, after a 
short term in culture, they become large, fl  at, irregularly shaped, 
and express acidic β-galactosidase activity, a marker of cellular 
senescence (Fig. 7 A; Dimri et al., 1995). Aging cells become un-
responsive to growth factors and cease proliferation (unpublished 
data). Senescent HEK cultures (2% BrdU incorporation in 24 h) 
were subjected to RNAi for p21 and/or p16 (Fig. 7 B). Inter-
ference with p21 induced reactivation of the cells, bringing 
  almost half of the population into the mitotic cycle. In these 
cells, p16 RNAi was almost equally effective, which is consistent 
with the known role of this inhibitor in establishing the replicative 
senescence of human cells (Fig. 7 C; Kiyono et al., 1998). Com-
bined interference for the two CKIs demonstrated almost no 
Figure 5.  CKIs can substitute for one another in preserving the postmitotic 
state. MEF-Mts p21
−/− were transfected with siRNAs for the indicated 
CKIs. (A) Western blot analysis of p57 performed 48 h after transfection 
with p57 siRNA. l ctr, loading control. (B) Percentages of BrdU-positive 
MEF-Mt p21
−/− measured 48 h after interference for single or multiple 
CKIs as indicated.
Figure 6.  Effects of CKI RNAi in serum-starved primary human foreskin 
ﬁ  broblasts. (A) Western blot analyses of p21, p27, p16, and p18 in cells 
transfected with siRNAs for the indicated CKIs. Lysates prepared 48 h after 
transfection. (B) BrdU-positive cells in cultures subjected to RNAi for the 
  indicated molecules. BrdU was added to culture medium 24 h after trans-
fection, and the cells were ﬁ  xed and stained 24 h later. Values are shown 
as means of up to three independent experiments with SDs (error bars) and 
are expressed relative to 10% serum-reactivated cells, which was set to 
100. (C) Growth curves of cells subjected to p21 interference. Cells were 
transfected with siRNA to p21 or were mock-transfected and counted at 
the indicated times after RNAi. Ctr, control siRNA; serum, cells re-fed with 
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synergy, suggesting that in this experimental system, unlocking 
either pathway is suffi  cient to induce cell cycle reentry. Similar 
results were obtained with senescent human foreskin fi  bro-
blasts. The depletion of p21 or p16 brought the majority of these 
cells back into the cell cycle (Fig. 7 D).
Although senescent cells are known to express high levels 
of inactive G1 cyclin–cdk complexes (Dulic et al., 1993), the 
reversal of senescence by direct removal of CKIs has not been 
shown before. Both HEK cells (Fig. 7 E) and fi  broblasts (not 
depicted) displayed abundant mitotic activity upon RNAi-
  mediated reactivation, which suggested that they could actually 
proliferate. To test this possibility, senescent HEK cells were 
transfected with p21 or p16 siRNA twice at a 48-h distance. 
Daily counts showed that the number of control-transfected 
cells did not increase in 3 d, whereas the CKI-interfered popula-
tions grew (Fig. 7 F). In particular, the cells transfected with 
p21 siRNA increased more than threefold over a 72-h period, 
showing that interference with p21 brings about not only cell 
cycle reentry but actual population growth. Cell cycle reactiva-
tion in either HEK cells or fi  broblasts did not cause any in-
crease in the spontaneous rate of cell death (Fig. 7, G and H). 
Altogether, these data allow us to conclude that senescent as 
well as TD and quiescent cells rely on the continuous presence 
of cell cycle inhibitors to maintain their nonproliferative state.
Discussion
In this study, we show that cells in such diverse nonproliferation 
states as terminal differentiation, quiescence, and replicative 
senescence can be allowed to reenter the cell cycle with com-
parable high effi  ciency simply by removing appropriate CKIs 
even in the absence of exogenous mitogenic stimuli. To de-
termine which molecules are most important in preventing 
cdk activation in TD myotubes, we selected an unbiased mass 
spectrometry–based approach. Such a strategy would be ef-
fective in un  covering both known and potentially unrecognized 
molecular brakes in our system. Immunoprecipitation/mass 
spectrometry experiments pointed at p21 as the main inhibitor 
in the C2C12 experimental system. Accordingly, interference 
with p21 was suffi  cient to reactivate the cell cycle in C2C12 
myotubes. The unexpected discovery that removal of CKIs allows 
full cell cycle reactivation in notoriously refractory TD cells led 
us to suspect that more pliable cell types might be reactivated 
by the same strategy. This hypothesis was fully confi  rmed by 
results obtained with quiescent as well as senescent cells.
Absolute quantitation of some of the CKIs present in 
myotubes and in quiescent fi  broblasts showed, somewhat sur-
prisingly, that the inhibitor playing the most substantial role 
in suppressing proliferation was not the most abundantly 
  expressed. In both mouse myotubes and resting human fi  bro-
blasts, p27 accumulates at much higher levels than p21 (Figs. S2 D 
and S4 D). However, the suppression of p21 is much more mo-
mentous than that of p27. Likewise, although in quiescent fi  bro-
blasts p16 protein levels are comparable with those of p21, the 
suppression of p16 is essentially inconsequential. There might be 
trivial explanations for these unexpected fi  ndings. For example, 
variable effectiveness in interfering with the different CKIs 
might skew the results. However, the large difference in the 
 molar concentrations of p27 versus p21 (60-fold) strongly suggests 
the existence of partially unrecognized functional differences 
between the two molecules.
Several points concerning specifi  c nonproliferation states 
are worth discussing. Myotubes are prototypic TD cells that are 
capable of resisting the mitogenic pressure of growth factors, 
Figure 7.  Effects of CKI RNAi in senescent 
HEK cells and human foreskin ﬁ  broblasts. 
(A) Acidic β-galactosidase staining of young 
and senescent HEK cells. (B) Western blot anal-
yses of p21 and p16 in HEK cells transfected 
with siRNAs for the indicated CKIs. Lysates 
prepared 48 h after RNAi. (C) Senescent HEK 
cells were subjected to RNAi for the indicated 
molecules. BrdU incorporation assay as in Fig. 
6 B. Percentages of BrdU-positive cells are 
shown after the subtraction of background. 
  Error bars represent SD. (D) BrdU incorporation 
in senescent ﬁ  broblasts. Assay performed as in 
Fig. 6 B. (E) Mitotic ﬁ  gures in senescent HEK 
cells transfected with p21 siRNA. Arrows point 
to mitotic ﬁ  gures. (F) Growth curves of HEK cell 
populations transfected with siRNAs for the 
indicated molecules. The cells were transfected 
twice, at 0 and 48 h. (G and H) Percentages 
of TUNEL-positive HEK cells and human ﬁ  bro-
blasts in cultures transfected with p21 siRNA. 
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retroviral oncogenes, and many positive cell cycle regulators 
that act as powerful proliferative stimuli in non-TD cells 
(  Tiainen et al., 1996a). The discovery of CKIs was quickly fol-
lowed by reports of the high expression of a variety of them in 
numerous TD histotypes (Parker et al., 1995; Gill et al., 1998; 
Zabludoff et al., 1998). However, they are generally viewed as 
an aid in cell cycle exit at the inception of terminal differentia-
tion (Missero et al., 1995) and as a safety feature against acci-
dental cell cycle reactivation after the establishment of the 
postmitotic state. Indeed, there is no previous demonstration 
that CKIs are essential for maintenance of the postmitotic state 
in TD cells. As already discussed above (see Introduction), 
knockout animals cannot address this point, as they already lack 
CKIs before the onset of terminal differentiation. Thus, the ap-
propriate means to investigate the role of inhibitory molecules 
in maintenance of the postmitotic state is to acutely ablate them 
after the establishment of this condition (Sage et al., 2003). Our 
results are all the more unexpected, as the functional suppres-
sion of p21 has been reported to be insuffi  cient to reactivate 
C2C12 myotubes (Mal et al., 2000). However, this conclusion 
was reached indirectly by suppressing p21 with an E1A mutant 
whose other functions are incompletely understood; moreover, 
the activity of the essential cdk4/6 kinase was not investigated.
The present results are consistent with our previous con-
clusion that the cdk4/6 kinase must be suppressed to conserve 
the postmitotic state. Conversely, activation of this specifi  c 
  kinase (but not other cdks) is suffi  cient to drive TD cells into 
S phase (Latella et al., 2001). Indeed, we show here that CKI 
removal results in the reactivation of cdk4 and cell cycle re  -
entry. For the fi  rst time, however, TD cells have been reactivated 
not through the forced expression of exogenous molecules but 
by the ablation of endogenous inhibitors, highlighting the exis-
tence of latent kinase complexes, whose presence had previ-
ously drawn little attention. Furthermore, in light of potential 
applications of our fi  ndings, it is certainly desirable to achieve 
cell cycle reactivation with a comparatively mild, reversible 
  manipulation of endogenous molecules.
Although the reactivation of quiescent fi  broblasts  by 
  antisense suppression of p21 has been described previously 
(Nakanishi et al., 1995), we show here that D cyclins are the main 
players in such reactivation, which is similar to our fi  nding in 
the myotubes. By analogy with TD muscle cells, resting fi  bro-
blasts possess considerable levels of preformed cyclin D–cdk4 
complexes, whose activity is counteracted by specifi  c CKIs.
At least two pathways are deeply involved in determining 
cell senescence: those of p53 and pRb. These two pathways 
concur to establish senescence proliferation arrest, at least in 
part, via p21 and p16. Although the roles of these two CKIs in 
initiating cell senescence are fi  rmly established, their contribu-
tion to the maintenance of this state is far less clear (Beausejour 
et al., 2003). Our data show that even after its attainment, repli-
cative senescence must be actively maintained by expressing 
high levels of cell cycle inhibitors. Removal of these CKIs 
brings about not only cell cycle reactivation but, at least in the 
short term, true cell proliferation. Whether CKI suppression is 
suffi  cient to overcome both the senescence and crisis barriers to 
immortalization remains to be investigated.
The absence of proliferation is usually thought of as a pas-
sive state deriving from the unavailability of key components of 
the cell cycle engine, with particular emphasis on G1 cyclins 
(Ekholm and Reed, 2000; Sherr and Roberts, 2004). In the present 
study, we show that TD, quiescent, and senescent cells can be 
reactivated by the sole removal of key CKIs. Thus, both tem-
porary and permanent growth arrest, far from being negatively 
determined states, entail a relentless commitment by the cell, 
which must actively maintain such states through the continuous, 
critical expression of inhibitors. As a corollary, these   results 
  imply that even cells in permanent, physiologically irreversible 
arrested states harbor functionally relevant levels of key cyclins 
whose unchecked activity is suffi  cient to reactivate the cell cycle. 
The biological role of these cyclins in apparently incongruous 
cellular environments remains to be investigated.
An ever-growing number of biotechnology applications 
requires large quantities of specifi  c cell types to be grown in the 
shortest possible time, provided that this goal can be achieved 
without introducing or causing harmful alterations in the cells 
themselves. An ideal proliferation-inducing/accelerating pro-
tocol should leave the cell’s genome and differentiative properties 
intact. A relatively gentle intervention such as reversible CKI 
removal might fulfi  ll these requirements, although its suitability 
for these purposes must be thoroughly investigated. We believe 
that the results summarized in this study have the potential to 
allow, facilitate, and/or accelerate wound healing, tissue repair, 
and in vitro culture of fastidious cell types. As CKIs are pivotal 
inhibitors of proliferation in all of the cases assessed, their sup-
pression could be exploited to induce the proliferation of cell 
types that cannot be currently cultured.
Materials and methods
Cells and adenoviruses
The mouse C2C12 myoblast cell line (Blau et al., 1985) was cultured as 
previously described (Latella et al., 2001). Differentiation was induced by 
plating the cells in DME containing 2% horse serum and 50 μM 1-β-D-
  arabinofuranosylcytosine (Latella et al., 2001). Myoblasts used as a reference 
were synchronized in mid-G1 phase to approximate myotubes synchro-
nously reactivated by CKI knockdown. Synchronization was obtained by 
serum starvation (2% horse serum) for 16 h followed by refeeding with 
20% FBS for 8 h. Primary MSCs were isolated and cultured as previously 
described (Rando and Blau, 1994; Tiainen et al., 1996a). Primary human 
satellite cells were cultured in growth medium (PromoCell) and induced to 
differentiate by plating them onto gelatin-coated dishes in DME containing 
5 μg/ml human insulin, 5 μg/ml human holotransferrin, and 50 μM 
1-β-D-arabinofuranosylcytosine for 6 d. Wild-type and p21
−/− MEFs were 
cultured in DME supplemented with 10% FBS (growth medium). MEF 
  conversion into muscle cells was obtained by infecting them with a recom-
binant adenovirus carrying MyoD at an infection multiplicity of 400. 4 d 
later, terminal differentiation was induced following the same protocol 
used for C2C12 myoblasts. Low passage human primary foreskin ﬁ  bro-
blasts (FB1329) were cultured in growth medium; quiescence was induced 
by switching conﬂ  uent cultures to 0.1% FBS for 48 h. Synchronization in 
mid-G1 phase, which was attained for the same reasons described for 
C2C12 cells, was achieved by serum starving nonconﬂ   uent cultures in 
0.1% FBS for 48 h followed by refeeding with 20% FBS for 8 h. Fibroblasts 
became senescent after prolonged culturing (passage >40). Primary HEK 
cells (a gift from S. Bacchetti, McMaster University, Hamilton, Ontario, 
Canada) were grown in α-MEM supplemented with 10% FBS and 2 mM 
L-glutamine. The overexpression of human cyclin D1 and cdk4 was obtained 
by coinfecting C2C12 myotubes with the corresponding recombinant 
  adenoviruses (Latella et al., 2001) at infection multiplicities of 15 and 150, 
respectively. Cultures were collected 24 h after infection and processed for 
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of dnK4 was obtained by infecting C2C12 myotubes or FB1329 cells with 
a recombinant adenovirus (Latella et al., 2001) at a multiplicity of infection 
of 800 or 150, respectively.
RNAi experiments
Target cells were transfected with the HiPerfect transfection reagent 
  (QIAGEN) complexed with siRNAs. We optimized the HiPerfect/siRNA ratio 
to obtain efﬁ  cient suppression of the target molecule with the smallest possible 
amounts of both reagents. RNAi for a single molecule in C2C12, MSC, 
and MEFs converted into myotubes was performed by complexing 6 μl 
  HiPerfect and 5 nM siRNA per 35-mm petri dish. Human satellite cell 
  myotubes, FB1329 ﬁ  broblasts, and HEK cells were interfered with 12 μl 
HiPerfect and 10 nM siRNA per 35-mm petri dish. RNAi for multiple mole-
cules was performed by adding each siRNA at a ﬁ  nal 5- or 10-nM concen-
tration, depending on the cell type, to the same volume of HiPerfect used 
in single transfections. Transfection complexes were kept in the culture 
  medium until the end of the experiment.
Immunoprecipitation, mass spectrometry, and kinase activity
To identify cdk4-associated molecules, C2C12 myotubes infected with hu-
man cyclin D1– and cdk4-carrying adenoviruses were lysed in cdk4 immuno-
precipitation buffer containing 20 mM Hepes, pH 7.5, 250 mM NaCl, 
5 mM MgCl2, 0.5 mM EGTA, 0.25% NP-40, 5 mM ATP, 1 mM DTT, 0.5 mM 
PMSF, 10 μg/ml aprotinin, 10 μg/ml chymostatin, and 20 μg/ml 
  leupeptin. Cell lysates were brieﬂ  y sonicated and centrifuged. The small-
scale analytical SDS-PAGE shown in Fig. 1 A was performed by immunoprecipi-
tating cdk4 from 1 mg of whole-cell protein extracts, whereas large-scale 
mass spectrometry sample preparation was performed as follows. 50 mg 
of protein extract was subjected to 4 h of immunoprecipitation with a mix-
ture of antibodies to cdk4: mouse mAb-1 and rabbit pAb-5 antibodies to 
human and mouse proteins, respectively (NeoMarkers), or control IgGs 
(Bioscience) bound to magnetic beads (Dynal). After extensive washes, the 
precipitates were detached from the antibodies by incubating the beads in 
0.1 M glycine buffer, pH 3, supplemented with 0.1% Triton X-100 for 15 min; 
the suspension was then neutralized with 0.75 M Tris, pH 8, boiled, and 
separated on a 4–12% polyacrylamide gel (NuPAGE; Invitrogen). Selected 
Coomassie-stained bands were removed and processed for mass spec-
trometry identiﬁ  cation. In brief, gel slices were excised, treated essentially 
as described previously (Shevchenko et al., 1996), and digested with 
modiﬁ   ed sequencing grade trypsin (Promega). Liquid chromatography/
mass spectometry/mass spectometry analyses were performed on an ion 
trap instrument (LCQ-DECA XP; Thermo Electron) equipped with a μ-ESI 
probe. Peptide mixtures were separated on a C18 BioBasic column (100 × 
0.18 mm; 5 μm; Thermo Electron) at a 2 μl/min ﬂ  ow rate using a 60-min 
linear gradient from 5 to 60% acetonitrile in 0.1% formic acid. Protein 
identiﬁ  cation was obtained using Bioworks Browser 3.1 software (Thermo 
Electron) and searching against a human protein database from the National 
Center for Biotechnology Information.
To evaluate cdk4 activity in C2C12 cells, myoblasts and myotubes 
were lysed in cdk4 immunoprecipitation buffer and treated as described 
for cdk4 immunoprecipitation. 1.8 mg of protein extract was subjected to 
4 h of immunoprecipitation with the anti-cdk4 antibody Ab-5 or control IgG 
bound to magnetic beads. After extensive washes, immunoprecipitates 
were resuspended in kinase buffer (Latella et al., 2001), and the kinase as-
say was performed on a GST-Rb fragment substrate (Santa Cruz Biotech-
nology, Inc.) as previously described (Latella et al., 2001). Labeled proteins 
were resolved on a 4–12% polyacrylamide gel and detected by auto-
radiography. To measure cyclin D1– and cyclin D3–associated kinase 
  activities in C2C12 cells, myoblasts and myotubes were lysed in cdk4 immuno-
precipitation buffer and treated as described for cdk4 immunoprecipitation. 
350 μg of protein extract was subjected to 3-h immunoprecipitation with 
anti–cyclin D1 (72-13G; Santa Cruz Biotechnology, Inc.) or –cyclin D3 
(C-16; Santa Cruz Biotechnology, Inc.) antibodies or control IgG bound to 
protein G–Sepharose beads (GE Healthcare). Kinase assay and auto-
radiography were performed as previously described (Latella et al., 2001). To 
assess cyclin E–associated kinase activity, C2C12 myotubes were lysed in 
immunoprecipitation buffer, brieﬂ  y sonicated, and centrifuged (Pajalunga 
and Crescenzi, 2004). 3 mg of protein extracts were immunoprecipitated 
for 3 h with an anti–cyclin E antibody (M-20; Santa Cruz Biotechnology, 
Inc.) or control IgG bound to magnetic beads. Immunoprecipitations were 
performed as previously described (Pajalunga and Crescenzi, 2004). 
  Labeled proteins were resolved on a 4–12% polyacrylamide gel and de-
tected by autoradiography. To characterize cdk4 and cdk6 complexes in 
human ﬁ  broblasts, proliferating and quiescent FB1329 cells were lysed 
in cdk4 immunoprecipitation buffer and treated as described for cdk4 
  immunoprecipitation. 1 mg of whole-cell lysates were subjected to 3 h of 
immunoprecipitation with anti-cdk4 or -cdk6 antibodies or control IgG bound 
to protein G–Sepharose beads.
Microscopy, immunoﬂ  uorescence, and acidic 𝗃-galactosidase assays
Pictures were obtained using a ﬂ  uoresence microscope (Axioskop 2; Carl 
Zeiss MicroImaging, Inc.) with a 20× NA 0.50 or a 40× NA 0.75 plan 
Neoﬂ  uar objective. Images were digitized with a camera (AxioCam; Carl 
Zeiss MicroImaging, Inc.) and acquired with AxioVision 3.1 software (Carl 
Zeiss MicroImaging, Inc.). Images were contrast enhanced by applying 
the brightness/contrast regulation of Photoshop 7.0 software (Macintosh 
  version) to the whole image. Double immunoﬂ  uorescence images were ob-
tained by superimposing two single-color pictures with Photoshop (Adobe). 
In immunoﬂ   uorescence procedures, mAbs to BrdU (Bu20a clone; Dako-
Cytomation) and myosin heavy chain (MyHC; MF20, Bader et al., 1982) 
were used. AlexaFluor488- or 594-conjugated antisera to mouse Igs were 
obtained from Invitrogen. Nuclei were counterstained with Hoechst 33258. 
HEK cultures were stained for acidic β-galactosidase activity as described 
previously (Dimri et al., 1995).
siRNAs
siGenome SMARTpool reagents (Dharmacon) composed of four siRNAs 
were used to interfere with the following human and mouse transcripts: 
  CDKN1A (p21), CDKN1B (p27; human only), CDKN1C (p57), CDKN2A 
(p16), CDKN2B (p15), CDKN2C (p18), CDKN2D (p19), CCND3 (cyclin 
D3), and CCND1 (cyclin D1). The antisense sequence of the Individual 
siGenome duplex (Dharmacon) for mouse p27 was 5′-P.U  A  U  C  C  C  G  G  C  A  G-
U  G  C  U  U  C  U  C  U  U  -3′. Individual siRNAs for mouse p21 and cyclin D3 
(siGENOME SMARTpool Upgrades; Dharmacon) were used in some ex-
periments; the antisense sequences are as follows: p21, #1 (5′-P.C  A  A  A  G  U  U  C-
C  A  C  C  G  U  U  C  U  C  G  U  U  -3′), #2 (5′-P.U  U  U  C  G  G  C  C  C  U  G  A  G  A  U  G  U  U  C  U  U  -3′), 
#3 (5′-P.C  A  A  C  G  G  C  A  C  A  C  U  U  U  G  C  U  C  C  U  U  -3′), and #4 (5′-P.G  A  A  C  A  G  G-
U  C  G  G  A  C  A  U  C  A  C  C  U  U  -3′); and cyclin D3, #1 (5′-P.A  A  U  C  A  C  G  G  C  A  G  C  C-
A  G  G  U  C  C  U  U  -3′), #2 (5′-P.U  A  U  A  G  A  U  G  C  A  A  A  G  C  U  U  C  U  C  U  U  -3′), #3 (5′-P.
C  U  C  G  C  A  G  G  C  A  G  U  C  C  A  C  U  U  C  U  U  -3′), and #4 (5′-P.U  A  C  C  U  A  G  A  A  G  C  U-
G  C  A  A  U  U  G  U  U  -3′). The siCONTROL Non-Targeting siRNA #2 (Dharmacon) 
was transfected as a control.
Western blot analyses
Proteins were separated on 4–12% polyacrylamide gels and analyzed 
by Western blotting with the following mAbs or pAbs: mAbs to cyclin D1 
(72-13G; Santa Cruz Biotechnology, Inc.), cyclin D2 (DCS-3; Abcam), p16 
and human cdk4 (both Ab-1; NeoMarkers), p27 (Transduction Laboratories), 
and β-tubulin (Sigma-Aldrich); pAbs to mouse cdk4 (Ab-5; NeoMarkers), 
p18 (Biosource International), and p16, p21, p57, cyclin D3, cdk2, cdk6, 
and cyclin E (Santa Cruz Biotechnology, Inc.). Peroxidase-conjugated 
  antisera to mouse and rabbit Igs were purchased from Bio-Rad Labo-
ratories. Western blots were developed using the SuperSignal kit (Pierce 
Chemical Co.). In immunoﬂ  uorescence procedures, mAbs to BrdU (Bu20a 
clone; DakoCytomation) and MyHC (MF20; Bader et al., 1982) were 
used. AlexaFluor-conjugated antisera to mouse Igs were obtained from 
  Invitrogen. Nuclei were counterstained with Hoechst 33258. HEK cultures 
were stained for acidic β-galactosidase activity as described previously 
(Dimri et al., 1995).
RT-PCR
In semiquantitative RT-PCR procedures, total cellular RNA was extracted 
from MSC-derived myotubes with TRIzol reagent (Life Technologies). 
cDNA synthesis and PCRs were performed starting from 1 μg of total 
cellular RNA using the GeneAmp Gold RNA PCR Reagent kit (Applied 
Biosystems). Individual CKIs were ampliﬁ  ed along with mouse β-actin in 
the same test tube. PCRs proceeded for 25 or 30 cycles (p15 or p16 and 
p19, respectively) on a personal machine (Mastercycler; Eppendorf). 
The following primers were used: p15 forward, 5′-G  C  C  C  A  A  T  C  C  A  G  G  T  C-
A  T  G  A  T  G  A  T  G  -3′; p15 reverse, 5′-G  A  T  G  G  G  G  C  T  G  G  G  G  A  G  A  A  A  G  A  A  G  -3′; 
p16 forward, 5′-G  T  C  G  C  A  G  G  T  T  C  T  T  G  G  T  C  A  C  T  G  -3′; p16 reverse, 5′-C  G  C-
A  C  G  A  T  G  T  C  T  T  G  A  T  G  T  C  C  C  -3′; p19 forward, 5′-G  T  C  T  G  C  G  T  C  G  G  C  G  A  C-
C  G  G  T  T  G  -3′; p19 reverse, 5′-C  A  G  G  A  G  C  T  A  G  G  A  A  G  C  T  G  A  C  C    A  C  G  -3′; 
β-actin forward, 5′-T  G  T  T  A  C  C  A  A  C  T  G  G  G  A  C  G  A  C  A  -3′; and β-actin reverse, 
5′-C  T  T  T  T  C  A  C  G  G  T  T  G  G  C  C  T  T  A  G  -3′.
Recombinant proteins and absolute quantitations
For absolute quantitation of CKIs in C2C12 and human ﬁ  broblasts, the fol-
lowing recombinant-tagged proteins were used as standards: mouse GST-
p21, poly-His-p27, and human GST-p16, -p21, and -p27. A dilution curve CKIS IN MAINTENANCE OF PROLIFERATION ARREST • PAJALUNGA ET AL. 817
of each reference protein was run on an SDS-PAGE gel along with the cell 
extracts or immunoprecipitates to be quantitated, and the proteins were 
analyzed by Western blotting. Developed ﬁ  lms were computer scanned 
and subjected to densitometry. The data thus acquired and the unknown 
samples (lysates or immunoprecipitates) were plotted as exempliﬁ  ed  in 
Fig. S4 F, yielding raw quantity estimates that were corrected to take into 
account the difference in the molecular weight of natural proteins and recom-
binant standards.
Densitometric evaluation of kinase assays
To directly compare the kinase activities associated with cyclin D1 and D3 
(Fig. 3), the densitometric measurements of pertinent bands (GST-Rb) were 
adjusted by subtracting their respective backgrounds (IgG). The adjusted 
values were then normalized for immunoprecipitation efﬁ  ciency,  which 
was calculated as follows: ODIP/ODTL × μgTL/μgIP × 100, where ODIP = OD 
of the immunoprecipitated protein (arbitrary units), ODTL = OD of the protein 
band in the total lysate (arbitrary units), μgTL = total lysate proteins loaded 
(micrograms), and μgIP = amount of total lysate subjected to immu  no-
precipitation (micrograms).
Online supplemental material
Fig. S1 shows p21 RNAi speciﬁ   city and the knockdown efﬁ  ciencies 
of other CKIs in mouse myotubes. Fig. S2 shows a characterization of 
  cyclin–cdk–CKI complexes and quantiﬁ  cation of total and cdk4-bound p21 
and p27 in mouse C2C12 cells. Fig. S3 shows cyclin D3 RNAi speciﬁ  city. 
Fig. S4 shows the expression of D-type cyclins, cdk4/6, p21, p27, and 
p16 and cyclin D–cdk4 complexes in proliferating and quiescent human 
ﬁ  broblasts. Online supplemental material is available at http://www.jcb.org/
cgi/content/full/jcb.200608109/DC1.
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